According to Inozyme Pharma's latest financial reports the company's current EPS (TTM) is -โน133.38. In 2022 the company made an earnings per share (EPS) of -โน162.63 a decrease over its 2021 EPS that were of -โน152.31.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน127.28 | -21.74% |
2022 | -โน162.63 | 6.78% |
2021 | -โน152.31 | -41.04% |
2020 | -โน258.34 | 130.75% |
2019 | -โน111.96 |